Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
about
Role of Hedgehog Signaling Pathway in NASHThe Natural Course of Non-Alcoholic Fatty Liver DiseaseNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistanceLiver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Hepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseLong Noncoding RNAs in Metabolic Syndrome Related DisordersA Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVSleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy ControlsRecommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisIncreased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Promising therapies for treatment of nonalcoholic steatohepatitis.NAFLD and liver transplantation: Current burden and expected challenges.Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin StudyMouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseNon-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials.Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patientsBariatric Surgery and Liver TransplantationPathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis.Non-alcoholic fatty liver disease: An expanded reviewNonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitisEffect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
P2860
Q26743373-C35B82E4-67B9-4E54-B790-4396BB11F6C7Q26746947-F26B4BB5-E6B2-4073-A1DB-E10916B29513Q26750955-457D77CF-61B0-49B4-ABFB-ED9DC2F4F505Q26752583-1E8125BF-6782-4DC2-BAC8-614D92ECBA91Q26778135-D1C2613A-0506-46B7-BC97-CC2B5911F415Q26780252-AE2E09B1-DD28-419B-B5B7-132042607C5BQ28066100-0C64C8B9-361A-499D-8E09-3C71D2BC8738Q28073491-30D6A7D8-C4C3-4BF9-85BA-9B47A89DEA91Q28074377-1C85CD08-1D36-4512-92C7-387EEC827795Q28079445-5484494A-AC5E-4A54-86D7-69561CE3F767Q28079826-864C2CE0-E6D4-402A-80C9-5588C1DCE0AFQ28551009-8FE9562D-BDE6-4F77-8D4E-7B72DAB91B22Q28607750-ABF0CD30-8B44-4E44-9EFE-B61B60C7F27FQ30238749-A20C9F54-A338-474E-A0FD-A8E17FA98A85Q30238933-024BB06C-8051-403A-8E8B-B929BBA19AE0Q30248535-6F3F3984-6714-4150-9148-F9C81AB02E9DQ30248578-AE52A7DE-71B7-4065-996E-544BA8547902Q30248646-3F238FC3-9393-42E8-A635-52CD80E6F480Q30249400-A3CBBBEE-17BE-4C56-A732-4F64D5508FDEQ30252463-8E0B84A0-2137-47C3-BA27-ED318259DFF5Q30355082-6FADCD66-0C7E-40DC-8D1D-B9B523CD4BE9Q30355958-542734EA-2471-4A12-AB67-53824901C63AQ30366569-8EFEAD44-7E6D-4F3E-AD04-FCE4FD04A96DQ30368624-91785F21-861C-43D3-B0D3-A6BA1645FA36Q30375036-0D4A121A-B78A-42A5-9DCE-B41E26BF0EA7Q30376231-54F7D98E-BEC3-48B1-9EEC-F72A10C2C7A8Q30382278-D472B66E-1A19-4C4F-93DD-3DDB41AB92D0Q30396916-0D40306F-F7E6-437E-9459-81A3FBB97C1EQ30413592-EBF95FB6-A882-4CC4-94D8-16BEEB65D560Q31134971-FD8A9911-B0BB-47FC-B3D8-B9B5636585FEQ33574413-85BA7B4E-C40B-4B52-8751-B0E4DDB4B4C6Q33627037-191FB36B-6DF0-4972-BC07-9783BAB2BFC9Q33711409-7CF41F46-12B8-4809-AEEE-61BBC664219DQ33734988-D9A54C45-8F14-4591-BCEF-3E25E1557FB1Q33789868-5EA05D8C-68FC-4CCB-A7BB-A06618256FF3Q33855157-98F62195-38C3-49DD-B2F0-9B5F38AD2500Q34757421-66FEFE75-70D5-43F6-A171-24AFEB17E79AQ35086412-C09EBC15-860E-46AD-A51D-5F64E11488F3Q35096971-EACC60E4-43A8-439B-911E-88C639DD0EB6Q35769495-B5BF7522-A946-4566-871B-3AFB03D2A67C
P2860
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fibrosis progression in nonalc ...... ysis of paired-biopsy studies.
@en
type
label
Fibrosis progression in nonalc ...... ysis of paired-biopsy studies.
@en
prefLabel
Fibrosis progression in nonalc ...... ysis of paired-biopsy studies.
@en
P2093
P2860
P921
P1476
Fibrosis progression in nonalc ...... ysis of paired-biopsy studies.
@en
P2093
Alina M Allen
Larry J Prokop
Rohit Loomba
Siddharth Singh
P2860
P304
643-54.e1-9; quiz e39-40
P356
10.1016/J.CGH.2014.04.014
P407
P577
2014-04-24T00:00:00Z